Cleared Traditional

K944772 - MULTIPLE ED1600 SERIES RADIATION SHIELDS (FDA 510(k) Clearance)

Class I Radiology device.

K944772 · Image Diagnostics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1994
Decision
23d
Days
Class 1
Risk

K944772 is an FDA 510(k) clearance for the MULTIPLE ED1600 SERIES RADIATION SHIELDS. Classified as Screen, Leaded, Operator Radiation Protector (product code EAK), Class I - General Controls.

Submitted by Image Diagnostics, Inc. (Sterling, US). The FDA issued a Cleared decision on October 20, 1994 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.6500 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Image Diagnostics, Inc. devices

Submission Details

510(k) Number K944772 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 1994
Decision Date October 20, 1994
Days to Decision 23 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 107d · This submission: 23d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code EAK Screen, Leaded, Operator Radiation Protector
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 892.6500
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.